KVA12123,Pembrolizumab
kineta bio,Merck
['kva12123', 'biomarker', '$ka']
#kineta unveils new #vista #biomarker data and #kva12123 phase 1/2 clinical trial update at #aacr23 $ka 
Follow top-line development in the oncology commercial domain through our award winning intelligence service, 1stOncology.